Janux Therapeutics (JANX) Amortizatization of Intangibles (2021 - 2026)

Janux Therapeutics (JANX) has 6 years of Amortizatization of Intangibles data on file, last reported at $2.6 million in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 37.83% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $16.0 million, a 22.72% increase from a year earlier, with the FY2025 full-year figure at $17.6 million, up 66.03% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $2.6 million, down from $3.5 million in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for JANX reached as high as $5.2 million in Q2 2025 and fell as low as $24000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $2.4 million across 5 years, with a median of $2.1 million in 2023.
• Across the five-year window, Amortizatization of Intangibles soared 6891.67% in 2023 and sank 37.83% in 2026, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $1.3 million in 2022, then soared by 59.52% to $2.1 million in 2023, then jumped by 42.02% to $2.9 million in 2024, then increased by 20.4% to $3.5 million in 2025, then decreased by 25.54% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $2.6 million in Q1 2026, $3.5 million in Q4 2025, and $4.6 million in Q3 2025.